Toronto - Delayed Quote CAD

Aurora Cannabis Inc. (ACB.TO)

5.66 -0.08 (-1.39%)

At close: October 30 at 4:00:00 PM EDT

Chart Range Bar

Loading chart for ACB.TO

Previous Close 5.74
Open 5.63
Bid 5.58 x --
Ask 5.70 x --
Day's Range 5.57 - 5.71
52 Week Range 3.59 - 8.75
Volume 271,477
Avg. Volume 420,443
Market Cap (intraday) 358.335M
Beta (5Y Monthly) 1.42
PE Ratio (TTM) --
EPS (TTM) -0.84
Earnings Date Nov 12, 2026
Forward Dividend & Yield -- (0.00%)
Ex-Dividend Date --
1y Target Est 5.82

Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis products in Canada and internationally. The company offers pharmaceutical-grade cannabis products; and medical and consumer cannabis products. It also provides harvested cannabis, trim, cannabis oils, capsules, edibles, vaporizers, dried and fresh cannabis, cannabis plants, cannabis seeds, edible cannabis, cannabis extracts, flowers, vapes / inhalable extracts, edibles / pastilles, concentrates, and cannabis topicals; and patient counseling and outreach services. Its brand portfolio includes Aurora, Being, CanniMed, CraftPlant, Daily Special, Drift, Greybeard, IndiMed, MedReleaf, Pedanios, San Raf, Tasty's, Whistler, and WMMC. The company also engages in pharmacy activities. Aurora Cannabis Inc. was founded in 2013 and is headquartered in Edmonton, Canada.

www.auroramj.com

1,028

Full Time Employees

March 31

Fiscal Year Ends

Healthcare

Sector

Drug Manufacturers - Specialty & Generic

Industry

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

ACB.TO

2.92%

S&P/TSX Composite index (^GSPTSE)

11.78%

1-Year Return

ACB.TO

16.02%

S&P/TSX Composite index (^GSPTSE)

18.03%

3-Year Return

ACB.TO

7.21%

S&P/TSX Composite index (^GSPTSE)

88.90%

5-Year Return

ACB.TO

93.11%

S&P/TSX Composite index (^GSPTSE)

69.32%

Earnings Per Share (GAAP)

Revenue vs. Earnings

yearly Annual

quarterly Quarterly

yearly Annual

quarterly Quarterly

Q1 FY27

Revenue 67.55M

Earnings -4.03M

Profit Margin -5.97%

FY26

FY27

-50M

50M

-60.0%

-40.0%

-20.0%

0.0%

Analyst Price Targets

4.00 Low

5.82 Average

5.66 Current

8.00 High

Analyst Recommendations

Strong Buy
Buy
Hold
Underperform
Sell

Valuation Measures

  
  
 Annual 

Market Cap
Enterprise Value
Trailing P/E
Forward P/E
PEG Ratio (current)
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue
Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

Profit Margin

-38.25%
Return on Assets (ttm)

-3.72%
Return on Equity (ttm)

-9.40%
Revenue (ttm)

314.07M
Net Income Avi to Common (ttm)

-52.47M
Diluted EPS (ttm)

-0.84

Balance Sheet and Cash Flow

Total Cash (mrq)

100.03M
Total Debt/Equity (mrq)

4.30%
Levered Free Cash Flow (ttm)

-20.04M

WEED.TO

CRON.TO

AC.TO

BB.TO

SHOP.TO

U.S. markets closed

Aurora Cannabis Inc. (ACB.TO)

3.66%

1.80%

21.20%

-2.92%

-16.02%

-93.11%

-97.30%

Aurora Cannabis Inc. Overview Drug Manufacturers - Specialty & Generic / Healthcare

Full Time Employees

Fiscal Year Ends

Sector

Industry

Recent News

Performance Overview

YTD Return

1-Year Return

3-Year Return

5-Year Return

Earnings Trends

Earnings Per Share (GAAP)

Revenue vs. Earnings

Analyst Insights

Analyst Price Targets

Analyst Recommendations

Statistics

Valuation Measures

Financial Highlights

Profitability and Income Statement

Balance Sheet and Cash Flow

Company Insights

Research Reports

People Also Watch